Skip to main content

Scientific Advisory Board

Our Scientific Advisory Board members are pioneers in interventional cardiology, having conducted first-in-human trials of key devices, including drug-eluting stents and bifurcation devices. They guide product design and research for regulatory approval and provide critical insights into addressing healthcare disparities in cardiovascular care. Their expertise ensures the ABS platform not only advances clinical outcomes but also expands access to cutting-edge treatment for underserved populations. As the platform progresses through clinical trials, they play a vital role in educating peers and shaping the future of interventional cardiology.

These 16 thought leaders drive awareness and adoption in interventional cardiology, influencing physician commercial success.
AlexAbizaid

Alex Abizaid, MD

Dante Pazzanese Institute, Sao Paulo, Brazil
AntonioColumbo

Antonio Columbo, MD

EMO GVM Columbus Heart Center, Milan Italy
Sameer Dani

Sameer Dani, MD

Ahmadabad, Gujrat, India
VladimirDzavik

Vladimir Dzavik, MD

Toronto General Hospital/UHN, Toronto, Canada
Neal Eigler MD

Neil Eigler, MD

Cedars-Sinai Medical Center, Los Angeles, CA
Saiball Kar MD

Saiball Kar, MD

Los Robles Health System, Thousand Oaks, CA
Moinakhar Lala MD

Moinakhar Lala, MD

Cedars-Sinai Medical Center, Los Angeles, CA
JensLassen

Jens Lassen, MD

Odense University Hospital, Denmark
Azeem Latib

Azeem Latib, MD

Montefiore Health System, New York, NY
Willie Lawrence, MD

Willie Lawrence, MD

Research Medical Center Kansas City, MO
FrankLitvack

Frank Litvak, MD

Cedars-Sinai Medical Center, Los Angeles, CA
YvesLoouvard

Yves Louvard, MD

ICPS, France
Raj Makar

Raj Makar, MD

Cedars-Sinai Medical Center, Los Angeles, CA
Roxana Mehran

Roxana Mehran, MD

Mount Sinai Hospital, New York, NY
Matthew Price MD

Matthew Price, MD

Scripps Clinic, La Jolla, CA
Danny Ramzy MD

Danny Ramzy, MD

UT Health Houston, TX